Skip to main content
JAMA
Vitamin E and cardiovascular health: does sex matter?
Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data.
Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.
Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices.
Accelerated approval and possible withdrawal of midodrine.
Clinical trial enrollment and progress in women's health.
Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
Evaluating sex differences in medical device clinical trials: time for action.
Healthy men should not take statins.
Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval.
